Editorial: More is Simply More and not Necessarily Better

No AccessJournal of UrologyClinical Urology: Editorial1 Jul 1996Editorial: More is Simply More and not Necessarily Better Robert A. Badalament Robert A. BadalamentRobert A. Badalament More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(01)65939-1AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Editorial: More is Simply More and not Necessarily Better." The Journal of Urology, 156(1), pp. 61–62 References 1 : Hernias of the Abdominal Wall. Philadelphia: W. B. Saunders Co.1980. Google Scholar 2 : The sensitivity of flow cytometry compared with conventional cytology in the detection of superficial bladder carcinoma. Cancer1987; 59: 2078. Google Scholar 3 : The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma. Cancer1987; 60: 1423. Google Scholar 4 : Consensus review of the clinical utility of DNA cytometry in bladder cancer. Report of the DNA Cytometry Consensus Conference. Cytometry1993; 14: 478. Google Scholar 5 Tribukait, B.: Flow cytometry in assessing the clinical aggressiveness of genito-urinary neoplasms. World J. Urol., 5: 108, 1087. Google Scholar 6 : Advances in the diagnosis and management of bladder cancer: flow cytometry, intravesical bacillus Calmette-Guerin, and systemic chemotherapy. J. Surg. Oncol.1989; 42: 33. Google Scholar 7 : Voided urine flow cytometry in screening high-risk patients for the presence of bladder cancer. J. Occup. Med.1990; 32: 894. Google Scholar 8 : The relative value of cytometry and cytology in the management of bladder cancer: the Memorial Sloan-Kettering Cancer Center experience. Sem. Urol.1988; 6: 22. Google Scholar 9 : Intravesical chemotherapy (mitomycin C) versus immunotherapy (bacillus Calmette-Guerin) in superficial bladder cancer. Eur. Urol.1991; 20: 19. Google Scholar 10 : Bladder cancer, 1996. CA1996; 46: 93. Google Scholar 11 : Use of pharmacologic data and computer simulations to design an efficacy trial of intravesical mitomycin C therapy for superficial bladder cancer. Cancer Chemother. Pharmacol.1993; 32: 255. Google Scholar Rochester Urology P.C., Crittenton Hospital, Rochester Hills, Michigan.© 1996 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited byJohnston B, Morales A, Emerson L and Lundie M (2018) RAPID PROTECTION OF BLADDER CANCER: A COMPARATIVE STUDY OF POINT OF CARE TESTSJournal of Urology, VOL. 158, NO. 6, (2098-2101), Online publication date: 1-Dec-1997.Sarosdy M (2018) EDITORIAL: DATA INTERPRETATION AND INTEGRATION OF NEW TESTS INTO CLINICAL PRACTICEJournal of Urology, VOL. 158, NO. 6, (2107-2108), Online publication date: 1-Dec-1997. Volume 156Issue 1July 1996Page: 61-62 Advertisement Copyright & Permissions© 1996 by American Urological Association, Inc.MetricsAuthor Information Robert A. Badalament More articles by this author Expand All Advertisement PDF downloadLoading ...